Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults

NCT ID: NCT06092632

Last Updated: 2023-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-13

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this clinical trial is to investigate whether the consumption of pigmented rice (black rice) in the diet improves cardiovascular health, specifically body weight, lipids, and glucose levels. It also aims to know whether people enjoyed eating pigmented rice and if they would continue eating it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this clinical trial is to test if pigmented rice consumption can lower the cardiometabolic risk factors of adults. The main question\[s\] it aims to answer are:

* Will pigmented rice significantly reduce lipid levels compared to white rice after six weeks?
* Will pigmented rice significantly reduce glucose levels compared to white rice after six weeks? Will pigmented rice significantly reduce weight and waist-hip ratio levels compared to white rice after six weeks? What are the participants' experiences in consuming pigmented rice?

Participants will consume black-pigmented rice for six weeks while maintaining their usual physical activity. Researchers will compare the white rice group and the black rice group to see if lowers cardiometabolic risk factors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidemias Overweight or Obesity Hyperglycaemia (Non Diabetic)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pigmented Rice

Cooked black pigmented rice will be consumed for six weeks (twice per day)

Group Type EXPERIMENTAL

Pigmented rice

Intervention Type OTHER

Cooked black rice

White Rice

Cooked white rice will be consumed by the control group for six weeks (twice per day)

Group Type PLACEBO_COMPARATOR

White Rice

Intervention Type OTHER

Cooked white rice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pigmented rice

Cooked black rice

Intervention Type OTHER

White Rice

Cooked white rice

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Black Rice

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 20-59 years.
* Body mass index between 18.5 -35 kg/m2
* Elevated cholesterol (total cholesterol \>200 mg/dL or LDL cholesterol 130-190 mg/dL), and/or impaired fasting glucose (100-125mg/dL)
* Eat rice as a staple food at least twice per day

Exclusion Criteria

* Are pregnant or lactating
* Regularly consume pigmented rice (two meals per day in the past 4 weeks)
* Have cardiovascular disease (hypertension, stroke, ischemic heart disease, myocardial infarction, or congestive heart failure) or diabetes mellitus
* Take cholesterol or glucose-lowering medications
* Have elevated blood pressure (\>130/80 mmHg)
* Have an illness that may influence lipid metabolism or metabolic rate (liver cirrhosis, pancreatitis, chronic kidney disease, hyperthyroidism, hypothyroidism)
* Take supplements that may influence lipids and glucose levels (including polyphenols)
* Are on a strict diet regimen (calorie-restricted or excluding food groups, examples: (Examples: Ketogenic diet, Intermittent fasting, No Rice diet)
* Have an active lifestyle (Ex. Goes to the gym daily, regularly (≥3 times a week) and perform vigorous activities such as lifting weights, swimming, cycling fast or uphill, or running, or athlete)
Minimum Eligible Age

20 Years

Maximum Eligible Age

59 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Santo Tomas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Diane S. Mendoza-Sarmiento

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alison M Hill, Ph.D

Role: PRINCIPAL_INVESTIGATOR

University of South Australia

Elizabeth H Arenas, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Santo Tomas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Santo Tomas

Manila, National Capital Region, Philippines

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Philippines

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USantoTomas

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Soy Nut Study on Markers of Health
NCT01173380 COMPLETED NA